ANIX Anixa Biosciences, Inc. - Common Stock
$2,67
السعر · مايو 20, 2026
البيانات الأساسية اعتبارًا من مارس 9, 2026
نطاق 52 أسبوعًا
$2–$5
8% of range
تقييم المحللين
BUY
10 analysts
السعر المستهدف
$11
+303% upside
P/E (TTM)
-12.1
ROE
-62.2%
هامش صافي الربح
—
ANIX لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
السعر
$2.67
القيمة السوقية
$136M
P/E (TTM)
-12.1
ربح السهم (آخر 12 شهرًا)
$-0.34
الإيرادات (آخر 12 شهرًا)
—
عائد التوزيعات
—
ROE
-62.2%
D/E الدين/حقوق الملكية
—
نطاق 52 أسبوعًا
$2 – $5
ANIX مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
Configure
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
الإيرادات وصافي الدخل
—
2017-10-31
→
2023-10-31
ربح السهم
$-0.34
2022-10-31
→
2025-10-31
التدفق النقدي الحر
—
2017-10-31
→
2020-10-31
الهوامش
—
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
المقياس
اتجاه 5 سنوات
ANIX
متوسط الأقران
P/E (TTM)
-12.1
15.6
P/B (السعر / القيمة الدفترية)
9.0
2.5
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
المقياس
اتجاه 5 سنوات
ANIX
متوسط الأقران
ROA (العائد على الأصول)
-58.0%
-59.2%
ROE
-62.2%
-104.5%
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
المقياس
اتجاه 5 سنوات
ANIX
متوسط الأقران
Current Ratio (النسبة الحالية)
8.1
3.2
Quick Ratio (النسبة السريعة)
7.7
—
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
المقياس
اتجاه 5 سنوات
ANIX
متوسط الأقران
Revenue YoY (الإيرادات مقارنة بالعام السابق)
0.00%
—
Revenue CAGR 3Y (معدل نمو الإيرادات السنوي المركب لـ 3 سنوات)
-25.7%
—
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
المقياس
اتجاه 5 سنوات
ANIX
متوسط الأقران
ANIX توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
شراء
10 محللين
- شراء قوي 2 20,0%
- شراء 7 70,0%
- احتفاظ 1 10,0%
- بيع 0 0,0%
- بيع قوي 0 0,0%
السعر المستهدف لمدة 12 شهرًا
4 محللين · 2026-05-20
الوسيط
$10.00
المتوسط
$10.75
← أقل من جميع الأهداف
$2.67
منخفض
$9.00
مرتفع
$14.00
السعر المستهدف الوسيط
$10.00
+274,5%
السعر المستهدف المتوسط
$10.75
+302,6%
سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
متوسط المفاجأة
0.01%
التقرير القادم
مايو 26, 2026
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 31 مارس، 2026 | $-0.08 | $-0.10 | 0.02% |
| 31 ديسمبر، 2025 | $-0.09 | $-0.09 | -0.00% |
| 30 سبتمبر، 2025 | $-0.07 | $-0.09 | 0.02% |
| 30 يونيو، 2025 | $-0.09 | $-0.10 | 0.01% |
| 31 مارس، 2025 | $-0.10 | $-0.10 | 0.00% |
مقارنة النظراء المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| ANIX | $136M | -12.1 | 0.00% | — | -62.2% | — |
| ALDX | $312M | -9.2 | — | — | -68.0% | — |
| ICCC | — | -51.2 | 4.3% | — | — | — |
| BMEA | $90M | -1.1 | -67.1% | -3326.0% | -216.6% | — |
| XGN | $139M | -6.5 | 19.7% | -30.0% | -103.7% | 58.3% |
| FBIO | — | — | — | — | — | — |
| ATRA | $132M | 7.0 | -6.3% | 27.1% | -88.9% | — |
| CUE | $29M | -1.1 | 195.8% | -96.9% | -119.3% | — |
| RNTX | — | -0.6 | — | — | — | — |
| CLNN | $64M | — | -41.5% | -13086.5% | 200.2% | — |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 14
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $210.0K | · | $512.0K | · | $250.0K | $1M | $362.5K | $300.0K | $9M | $4M | |
| R&D Expense | $5M | $6M | $5M | $7M | $6M | $4M | $5M | $7M | $2M | $2M | $711.4K | · | |
| SG&A Expense | $7M | $7M | $6M | $7M | $7M | $6M | $6M | $7M | $4M | $3M | $6M | $6M | |
| Operating Expenses | $12M | $14M | $11M | $14M | $14M | $10M | $12M | $15M | $6M | $5M | $10M | $9M | |
| Operating Income | $-12M | $-14M | $-11M | $-14M | $-13M | $-10M | $-12M | $-14M | $-6M | $-5M | $-944.8K | $-5M | |
| Interest Expense | · | · | · | · | · | · | · | · | $500.5K | $519.9K | $451.9K | $1M | |
| Interest Income | · | · | · | · | · | · | $71.4K | $46.0K | $19.4K | $12.5K | $17.6K | $8.6K | |
| Pretax Income | · | · | · | · | · | · | $-12M | $-14M | $-5M | $-5M | $-1M | $-10M | |
| Net Income | $-11M | $-13M | $-10M | $-14M | $-13M | $-10M | $-12M | $-14M | $-5M | $-5M | $-1M | $-10M | |
| EPS (Basic) | $-0.34 | $-0.39 | $-0.32 | $0.45 | $-0.45 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.34 | $-0.39 | $-0.32 | $0.45 | · | · | · | · | · | · | · | · | |
| Shares (Basic) | 32,454 | 31,898 | 30,980 | 30,374 | · | · | · | · | · | · | · | · | |
| Shares (Diluted) | 32,454 | 31,898 | 30,980 | 30,374 | 28,579,000 | · | · | · | · | · | · | · | |
| EBITDA | $-12M | $-14M | $-11M | $-14M | $-13M | $-10M | · | $-14M | $-6M | $-5M | $-944.8K | · |
الميزانية العمومية 23
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1M | $1M | $915.0K | $12M | $29M | $6M | $3M | $3M | $3M | $2M | $4M | $3M | |
| Short-term Investments | $14M | $19M | $23M | $17M | $7M | $3M | $2M | $2M | $4M | $750.0K | $2M | $2M | |
| Receivables | · | $173.0K | $270.0K | $46.0K | · | $2.2K | $66.5K | $307.0K | · | · | · | $400.0K | |
| Prepaid Expense | $713.0K | $1M | $1M | $467.0K | $276.0K | $311.6K | $185.0K | $175.5K | $174.6K | $162.1K | $126.5K | $60.6K | |
| Current Assets | $16M | $21M | $25M | $30M | $36M | $9M | $6M | $6M | $7M | $3M | $7M | $6M | |
| PP&E (Net) | · | · | · | · | · | · | $200.6K | $72.7K | $52.7K | $156.6K | $43.5K | $11.9K | |
| Accum. Depreciation | · | · | · | · | · | $0 | $95.0K | $53.8K | $35.7K | $47.0K | $13.6K | $48.8K | |
| Total Assets | $16M | $22M | $26M | $30M | $36M | $9M | $6M | $6M | $9M | $6M | $9M | $9M | |
| Accounts Payable | $165.0K | $525.0K | $206.0K | $265.0K | $136.0K | $232.4K | $585.8K | $582.0K | $480.3K | $373.2K | $374.7K | $540.2K | |
| Accrued Liabilities | $2M | $2M | $2M | $2M | $1M | $901.0K | $895.5K | $683.1K | $409.2K | $95.5K | · | · | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | $468.8K | $380.8K | · | |
| Current Liabilities | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $889.5K | $468.8K | $593.8K | $2M | |
| Capital Leases | $163.0K | $203.0K | $123.0K | $175.0K | $220.0K | · | · | · | · | · | · | · | |
| Total Liabilities | $2M | $3M | $2M | $2M | $1M | $1M | $1M | · | $889.5K | $5M | $4M | $5M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | $370.2K | · | |
| Total Debt | · | · | · | · | · | · | · | · | · | $468.8K | · | · | |
| Common Stock | $330.0K | $322.0K | $311.0K | $309.0K | $301.0K | $242.5K | $203.3K | $189.1K | $166.0K | $87.5K | $87.2K | $87.9K | |
| Paid-in Capital | $267M | $260M | $252M | $247M | $240M | $200M | $187M | $175M | $164M | $152M | $151M | $149M | |
| Retained Earnings | $-252M | $-241M | $-228M | $-218M | $-205M | $-192M | $-182M | $-170M | $-156M | $-151M | $-146M | $-145M | |
| Treasury Stock | · | $6.0K | · | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $15M | $20M | $24M | $29M | $35M | $9M | $5M | $5M | $8M | $987.5K | $5M | $4M | |
| Liabilities + Equity | $16M | $22M | $26M | $30M | $36M | $9M | $6M | $6M | $9M | $6M | $9M | $9M | |
| Shares Outstanding | 33,013,829 | 32,196,862 | 31,145,219 | 30,913,902 | 30,050,894 | 24,248,695 | 20,331,754 | 18,908,632 | 16,602,759 | 8,752,387 | 8,724,878 | 8,788,176 |
التدفق النقدي 12
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $18.4K | $43.2K | $33.3K | $12.5K | · | |
| Stock-based Comp | $4M | $4M | $4M | $6M | $8M | $4M | · | · | · | · | · | $2M | |
| Amort. of Intangibles | · | · | · | · | · | · | $418.8K | $325.3K | $325.3K | $325.3K | $325.3K | $314.5K | |
| Operating Cash Flow | $-7M | $-7M | $-6M | $-6M | $-5M | $-6M | $-5M | $-4M | $-4M | $-3M | $1M | $-2M | |
| CapEx | · | · | · | · | · | $15.8K | $175.5K | $38.4K | $30.2K | $146.5K | $54.8K | $6.7K | |
| Investing Cash Flow | $5M | $4M | $-6M | $-11M | $-4M | $-305.8K | $-525.5K | $1M | $-3M | $2M | $45.2K | $-3M | |
| Stock Issued | $2M | $3M | · | · | $11M | $9M | $6M | $2M | $3M | · | · | $4M | |
| Stock Repurchased | · | $6.0K | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $2M | $3M | · | · | $11M | $9M | · | $2M | $3M | · | · | · | |
| Financing Cash Flow | $2M | $3M | $366.0K | $452.0K | $32M | $9M | $6M | $3M | $7M | $-2.7K | $-400.6K | $7M | |
| Net Change in Cash | $-27.0K | $356.0K | $-11M | $-17M | $23M | $3M | $435.7K | $-283.5K | $851.1K | $-2M | $1M | $2M | |
| Free Cash Flow | · | · | · | · | · | $-6M | · | $-4M | $-4M | $-4M | $1M | · |
الربحية 6
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -6586.2% | -5243.3% | · | -2563.1% | · | · | -1284.4% | -1676.0% | -1503.0% | -10.2% | · | |
| Net Margin | · | -5978.1% | -4671.9% | · | -2527.7% | · | · | -1258.1% | -1935.9% | -1672.1% | -14.9% | · | |
| Pretax Margin | · | · | · | · | · | · | · | -1280.3% | -1381.8% | -1672.1% | -14.9% | · | |
| EBITDA Margin | · | -6586.2% | -5243.3% | · | -2563.1% | · | · | -1284.4% | -1676.0% | -1503.0% | -10.2% | · | |
| ROA | -58.0% | -53.3% | -35.1% | -40.8% | -56.7% | -106.0% | · | -183.4% | -97.2% | -67.0% | -15.0% | · | |
| ROE | -62.2% | -56.6% | -36.8% | -42.2% | -58.6% | -143.2% | · | -209.6% | -157.5% | -166.1% | -30.4% | · |
السيولة والملاءة 4
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.1 | 8.5 | 12.5 | 14.8 | 28.3 | 7.9 | · | 4.4 | 7.9 | 7.3 | 11.6 | · | |
| Quick Ratio | 7.7 | 8.0 | 11.9 | 14.6 | 28.1 | 7.6 | · | 4.0 | 7.7 | 6.9 | 11.4 | · | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | 0.5 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -12.1 | -8.7 | -2.1 | · |
الكفاءة 2
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | 0.0 | · | 0.0 | · | · | 0.1 | 0.1 | 0.0 | 1.0 | · | |
| Receivables Turnover | · | 0.9 | 1.3 | · | · | · | · | · | · | · | · | · |
معدلات النمو 2
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | 0.00% | · | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | -25.7% | · | · | · | · | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 14
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | $210.0K | · | $512.0K | · | $250.0K | $1M | $362.5K | $300.0K | $9M | $4M | |
| Net Income TTM | $-11M | $-13M | $-10M | $-14M | $-13M | $-10M | $-12M | $-14M | $-5M | $-5M | $-1M | $-10M | |
| Market Cap | $136M | $113M | $98M | $173M | $143M | $50M | · | $77M | $34M | $56M | $32M | · | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | $53M | · | · | |
| P/E | -12.1 | -9.0 | -9.9 | 12.4 | · | · | · | · | · | · | · | · | |
| P/S | · | · | 468.7 | · | 280.0 | · | · | 68.8 | 93.9 | 185.3 | 3.5 | · | |
| P/B | 9.0 | 5.6 | 4.0 | 6.0 | 4.0 | 5.7 | · | 14.1 | 4.3 | 56.3 | 6.4 | · | |
| P / Tangible Book | 9.0 | 5.6 | 4.0 | 6.0 | 4.0 | 5.7 | · | · | · | · | · | · | |
| P / Cash Flow | -19.0 | -15.4 | -15.9 | -26.7 | -29.0 | -8.1 | · | -17.9 | -9.0 | -16.4 | 23.8 | · | |
| P / FCF | · | · | · | · | · | -8.1 | · | -17.8 | -8.9 | -15.8 | 24.8 | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | -11.7 | · | · | |
| EV / FCF | · | · | · | · | · | · | · | · | · | -15.0 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | 176.0 | · | · | |
| Earnings Yield | -8.2% | -11.1% | -10.1% | 8.0% | · | · | · | · | · | · | · | · |
قائمة الدخل 11
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | $210.0K | · | · | · | $0 | |
| R&D Expense | $1M | $1M | $1M | $1M | $2M | $1M | $2M | $2M | $1M | $2M | $1M | $998.0K | $1M | $2M | $1M | $2M | |
| SG&A Expense | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $1M | $2M | $1M | $2M | |
| Operating Expenses | $3M | $3M | $2M | $3M | $3M | $3M | $4M | $3M | $4M | $3M | $3M | $3M | $3M | $4M | $3M | $4M | |
| Operating Income | $-3M | $-3M | $-2M | $-3M | $-3M | $-3M | $-4M | $-3M | $-4M | $-3M | $-3M | $-3M | $-3M | $-4M | $-3M | $-4M | |
| Net Income | $-3M | $-3M | $-2M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-2M | $-2M | $-3M | $-3M | $-4M | |
| EPS (Basic) | $-0.08 | $-0.08 | $-0.07 | $-0.09 | $-0.10 | $-0.09 | $-0.10 | $-0.10 | $-0.10 | $-0.25 | $-0.08 | $-0.07 | $0.08 | $0.79 | $-0.09 | $-0.12 | |
| EPS (Diluted) | $-0.08 | $-0.08 | $-0.07 | $-0.09 | $-0.10 | $-0.09 | $-0.10 | $-0.10 | $-0.10 | $-0.25 | $-0.08 | $-0.07 | $0.08 | $0.78 | $-0.09 | · | |
| Shares (Basic) | 33,240,000 | -96,842,546 | 32,476,000 | 32,202,000 | 32,197,000 | -95,382,102 | 32,054,000 | 31,914,000 | 31,446,000 | -61,845 | 30,974 | 30,930 | 30,921 | 130 | 30,451 | · | |
| Shares (Diluted) | 33,240,000 | -96,842,546 | 32,476,000 | 32,202,000 | 32,197,000 | -95,382,102 | 32,054,000 | 31,914,000 | 31,446,000 | -61,845 | 30,974 | 30,930 | 30,921 | -60,354 | 30,451 | 30,152 | |
| EBITDA | $-3M | · | $-2M | $-3M | $-3M | · | $-4M | $-3M | $-4M | · | $-3M | $-3M | $-3M | · | $-3M | $-4M |
الميزانية العمومية 18
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $1M | $1M | $2M | $1M | $1M | $1M | $995.0K | $998.0K | $915.0K | $3M | $6M | $10M | $12M | $24M | $28M | |
| Short-term Investments | $13M | $14M | $15M | $14M | $16M | $19M | $20M | $22M | $23M | $23M | $22M | $21M | $18M | $17M | $7M | $4M | |
| Receivables | · | · | · | · | · | $173.0K | $410.0K | $218.0K | $391.0K | $270.0K | $334.0K | $256.0K | $147.0K | $46.0K | · | · | |
| Prepaid Expense | $848.0K | $713.0K | $1M | $1M | $1M | $1M | $2M | $757.0K | $1M | $1M | $532.0K | $178.0K | $256.0K | $467.0K | $676.0K | $332.0K | |
| Current Assets | $15M | $16M | $17M | $17M | $19M | $21M | $23M | $24M | $25M | $25M | $26M | $27M | $28M | $30M | $32M | $33M | |
| Total Assets | $15M | $16M | $18M | $17M | $19M | $22M | $23M | $24M | $25M | $26M | $27M | $28M | $28M | $30M | $33M | $33M | |
| Accounts Payable | $148.0K | $165.0K | $276.0K | $284.0K | $600.0K | $525.0K | $302.0K | $215.0K | $364.0K | $206.0K | $94.0K | $195.0K | $110.0K | $265.0K | $227.0K | $93.0K | |
| Accrued Liabilities | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | $1M | $2M | $1M | $1M | |
| Current Liabilities | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $1M | $1M | |
| Capital Leases | $151.0K | $163.0K | $174.0K | $184.0K | $194.0K | $203.0K | $213.0K | $93.0K | $108.0K | $123.0K | $136.0K | $149.0K | $162.0K | $175.0K | $187.0K | $202.0K | |
| Total Liabilities | $1M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $1M | |
| Common Stock | $335.0K | $330.0K | $328.0K | $322.0K | $322.0K | $322.0K | $321.0K | $320.0K | $318.0K | $311.0K | $310.0K | $310.0K | $309.0K | $309.0K | $307.0K | $302.0K | |
| Paid-in Capital | $269M | $267M | $265M | $262M | $261M | $260M | $259M | $258M | $256M | $252M | $251M | $249M | $248M | $247M | $246M | $244M | |
| Retained Earnings | $-254M | $-252M | $-249M | $-247M | $-244M | $-241M | $-238M | $-235M | $-231M | $-228M | $-226M | $-223M | $-221M | $-218M | $-215M | $-212M | |
| Treasury Stock | · | · | · | · | $6.0K | $6.0K | · | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $15M | $15M | $17M | $16M | $18M | $20M | $22M | $24M | $25M | $24M | $26M | $27M | $28M | $29M | $32M | $32M | |
| Liabilities + Equity | $15M | $16M | $18M | $17M | $19M | $22M | $23M | $24M | $25M | $26M | $27M | $28M | $28M | $30M | $33M | $33M | |
| Shares Outstanding | 33,463,440 | 33,013,829 | 32,822,109 | 32,211,092 | 32,196,862 | 32,196,862 | 32,146,460 | 32,006,460 | 31,754,375 | 31,145,219 | 31,017,770 | 30,958,665 | 30,922,830 | 30,913,902 | 30,653,418 | 30,154,708 |
التدفق النقدي 7
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $768.0K | $859.0K | $829.0K | $962.0K | $1M | $980.0K | $1M | $1M | $1M | $1M | $1M | $1M | $957.0K | $1M | $1M | $1M | |
| Operating Cash Flow | $-3M | $-1M | $-2M | $-2M | $-3M | $-927.0K | $-3M | $-1M | $-2M | $-2M | $-1M | $-807.0K | $-2M | $-2M | $-1M | $-2M | |
| Investing Cash Flow | $1M | $654.0K | $-833.0K | $2M | $3M | $867.0K | $3M | $556.0K | $129.0K | $-593.0K | $-980.0K | $-3M | $-585.0K | $-10M | $-3M | $250.0K | |
| Stock Issued | · | $454.0K | $2M | $14.0K | $-17.0K | $-29.0K | $-45.0K | $833.0K | $2M | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | $-17.0K | · | · | · | $2M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $2M | $350.0K | $2M | $18.0K | $-17.0K | $106.0K | $149.0K | $897.0K | $2M | $279.0K | $3.0K | $81.0K | $3.0K | $-384.0K | $829.0K | · | |
| Net Change in Cash | $303.0K | $-251.0K | $-415.0K | $857.0K | $-218.0K | $46.0K | $230.0K | $-3.0K | $83.0K | $-2M | $-2M | $-4M | $-3M | $-12M | $-3M | $-2M |
الربحية 5
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | -1219.0% | · | · | · | · | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | -1089.5% | · | · | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | -1219.0% | · | · | · | · | |
| ROA | -15.0% | · | -11.1% | -13.5% | -14.4% | · | -13.2% | -12.1% | -12.1% | · | -8.5% | -7.6% | -7.3% | · | -7.9% | -9.9% | |
| ROE | -15.6% | · | -11.8% | -14.1% | -15.0% | · | -13.9% | -12.4% | -12.4% | · | -8.8% | -7.8% | -7.5% | · | -8.1% | -10.2% |
السيولة والملاءة 2
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.2 | · | 8.4 | 8.9 | 9.3 | · | 11.3 | 14.4 | 15.2 | · | 14.2 | 17.8 | 22.8 | · | 22.0 | 27.4 | |
| Quick Ratio | 11.5 | · | 7.8 | 8.3 | 8.6 | · | 10.6 | 14.0 | 14.6 | · | 13.9 | 17.7 | 22.6 | · | 21.6 | 27.1 |
الكفاءة 2
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | · | · | · | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | 1.5 | · | · | · | · |
التقييم (آخر 12 شهرًا) 7
| المقياس | اتجاه | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-11M | · | $-12M | $-12M | $-13M | · | $-12M | $-11M | $-10M | · | $-10M | $-11M | $-12M | · | $-14M | $-14M | |
| Market Cap | $100M | · | $100M | $90M | $93M | · | $107M | $95M | $144M | · | $111M | $126M | $135M | · | $116M | $98M | |
| P/E | -8.8 | · | -8.5 | -7.2 | -7.2 | · | -8.7 | -8.5 | -26.7 | · | -22.4 | · | · | · | · | · | |
| P/B | 6.7 | · | 6.1 | 5.6 | 5.2 | · | 4.9 | 4.0 | 5.9 | · | 4.4 | 4.7 | 4.9 | · | 3.7 | 3.0 | |
| P / Tangible Book | 6.7 | · | 6.1 | 5.6 | 5.2 | · | 4.9 | 4.0 | 5.9 | · | 4.4 | 4.7 | 4.9 | · | 3.7 | 3.0 | |
| P / Cash Flow | -38.5 | · | · | · | -32.2 | · | · | · | -62.4 | · | · | · | -68.0 | · | · | · | |
| Earnings Yield | -11.3% | · | -11.8% | -14.0% | -13.8% | · | -11.5% | -11.8% | -3.7% | · | -4.5% | · | · | · | · | · |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | |
|---|---|---|---|---|---|
| الإيرادات | — | — | $210.0K | — | $512.0K |
| هامش الربح التشغيلي % | — | -6586.2% | -5243.3% | — | -2563.1% |
| صافي الدخل | $-11M | $-13M | $-10M | $-14M | $-13M |
| EPS المخفف | $-0.34 | $-0.39 | $-0.32 | $0.45 | — |
الميزانية العمومية
| 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | |
|---|---|---|---|---|---|
| النسبة الحالية | 8.1 | 8.5 | 12.5 | 14.8 | 28.3 |
| النسبة السريعة | 7.7 | 8.0 | 11.9 | 14.6 | 28.1 |
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
📊
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.